###begin article-title 0
Myogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy
###end article-title 0
###begin p 1
These authors contributed equally to this work.
###end p 1
###begin p 2
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 237 242 <span type="species:ncbi:10090">mouse</span>
Duchenne muscular dystrophy is caused by dystrophin mutations that lead to structural instability of the sarcolemma membrane, myofiber degeneration/regeneration and progressive muscle wasting. Here we show that myogenic Akt signaling in mouse models of dystrophy promotes increased expression of utrophin, which replaces the function of dystrophin thereby preventing sarcolemma damage and muscle wasting. In contrast to previous suggestions that increased Akt in dystrophy was a secondary consequence of pathology, our findings demonstrate a pivotal role for this signaling pathway such that modulation of Akt can significantly affect disease outcome by amplification of existing, physiological compensatory mechanisms.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C1">1</xref>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C3">3</xref>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C4">4</xref>
###xml 762 763 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C5">5</xref>
###xml 926 927 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C3">3</xref>
###xml 928 929 906 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C6">6</xref>
###xml 930 932 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C10">10</xref>
###xml 1264 1272 <span type="species:ncbi:9606">patients</span>
Muscular dystrophy describes a group of genetic disorders generally characterized by progressive muscle weakness. The most common form of muscular dystrophy, Duchenne muscular dystrophy (DMD), is caused by primary mutations in the dystrophin gene (1-3). DMD is characterized by progressive muscle weakness eventually leading to cardiac and respiratory failure. Dystrophin deficiency alters the stability of the entire dystrophin-glycoprotein complex (DGC) resulting in reduction of the entire complex at the plasma membrane (for review 4). In skeletal muscle fibers, the core components of the DGC include dystrophin, the dystroglycans (alpha- and beta-DG), the sarcoglycans (alpha-, beta-, gamma- and delta-SG), sarcospan (SSPN) and the syntrophins (for review 5). Peripheral and integral membrane components of the DGC provide a physical connection between the extracellular matrix and the intracellular actin cytoskeleton (3,6-10). Loss of dystrophin and the DGC alters the integrity of the sarcolemma, the skeletal muscle plasma membrane, increasing contraction-induced damage. Even though skeletal muscle possesses the innate ability to regenerate, this ability is insufficient to compensate for the structural damage endured during muscle contraction in DMD patients. Thus, the link between the extracellular membrane and the intracellular cytoskeleton provided by the DGC is essential for maintaining sarcolemmal stability.
###end p 5
###begin p 6
###xml 298 301 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C11">11</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C12">12</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C13">13</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C17">17</xref>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C13">13</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C11">11</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C12">12</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C18">18</xref>
###xml 261 269 <span type="species:ncbi:9606">patients</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
The regenerative capacity of skeletal muscle is insufficient in combating persistent and widespread degeneration of myofibers with structural defects in the sarcolemma. Akt, a serine/threonine protein kinase, has previously been shown to be altered in both DMD patients and in dystrophin-deficient mdx mice (11,12). Previous reports indicate that activation of the phosphatidylinositol 3-kinase (PI(3)K)/Akt pathway is critical for the activation of muscle hypertrophy (13-17). We and others have established that the same PI(3)K/Akt signaling pathways responsible for inducing skeletal muscle hypertrophy (13) are also activated in many forms of muscular dystrophy (11,12). Furthermore, we have recently demonstrated that direct manipulation of Akt in normal, wild-type (WT) mice induces skeletal muscle hypertrophy that results in dramatic improvements in force generation while decreasing adipose mass (18). Taken together, these previous reports indicate activation of Akt in dystrophic muscle may be a key mediator of the hypertrophic response both in the promotion of muscle hypertrophy and in blood vessel recruitment.
###end p 6
###begin p 7
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C20">20</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C20">20</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C11">11</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C18">18</xref>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C18">18</xref>
###xml 690 695 <span type="species:ncbi:10090">mouse</span>
The Akt family of protein kinases is activated by numerous extracellular stimuli transduced across the membrane through membrane-bound receptor tyrosine kinases (for review 20). Akt is then recruited to the plasma membrane through activation of PI(3)K. Subsequent phosphorylation releases Akt from the plasma membrane and leads to translocation of phosphorylated Akt (P-Akt) to the cytoplasm and activation of downstream targets. Although recent research has reported Akt translocation to the nucleus following activation (for review 20), Akt remains in the cytosolic fraction following activation in skeletal muscle (11). We have created a skeletal muscle-specific, conditional transgenic mouse expressing a constitutively active form of Akt (18). In this study, an increase in Akt activation in skeletal muscle led to muscle hypertrophy specifically in type IIb fibers. The induction of hypertrophy was also accompanied by increased fiber strength, decreased fat mass and improvement of metabolic parameters (18). These findings indicate that Akt activation alone can increase muscle mass and improve muscle strength.
###end p 7
###begin p 8
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C18">18</xref>
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 585 588 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 849 852 849 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C21">21</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C22">22</xref>
###xml 1024 1027 1024 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
In the current report, we examined the effect of constitutive Akt activation on the dystrophic pathology in dystrophin-deficient mdx mice. We demonstrate that activation of the Akt transgene at the prenectroic (<3.5 weeks of age) stage of disease delays the onset of dystrophic pathology in mdx mice. We exploited the conditional transgene (18) to activate the transgene for a total of 3 weeks before analyzing the tissue for signs of muscular dystrophy. We show an increase in muscle hypertrophy and decreased sarcolemmal fragility in Akt-treated mdx mice compared with the untreated mdx controls. The mechanism of amelioration involves increased expression and wider distribution of adhesion complexes including the utrophin-glycoprotein complex (UGC). Overexpression of the UGC has previously been shown to ameliorate the dystrophic pathology in mdx mice (21,22). These findings suggest that the overexpression and extra-synaptic localization of the UGC and integrin compensate for the loss of the DGC in Akt-transgenic, mdx mice. This current study identifies myogenic Akt signaling as a drug target that could improve the muscle wasting and sarcolemmal fragility associated with muscular dystrophy by increasing expression of the UGC.
###end p 8
###begin title 9
RESULTS AND DISCUSSION
###end title 9
###begin title 10
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
Generation of mdx mice with inducible Akt1 expression in skeletal muscle
###end title 10
###begin p 11
###xml 168 179 168 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 184 192 184 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C18">18</xref>
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F1">1</xref>
###xml 299 310 299 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 314 322 314 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 629 632 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>mdx</italic></sup>
###xml 633 635 633 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 747 750 747 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 827 830 827 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 827 830 827 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>mdx</italic></sup>
###xml 1046 1049 1046 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1058 1061 1058 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
To investigate whether the beneficial effects of Akt would manifest in dystrophic muscle, we engineered mice with muscular dystrophy to express Akt1 by introducing the TRE-myrAkt1 and MCK-rtTA transgenes (18) into dystrophin-deficient mdx mice (Fig. 1). Offspring that had inherited only one of the TRE-myrAkt1 or MCK-rtTA transgenes are referred to as single-transgenic (STG) mice and lack the means for the conditional activation of Akt1. Double-transgenic (DTG) offspring inherited both of the transgenes and increase expression of Akt1 upon doxycycline (DOX) treatment. All female offspring are heterozygous for dystrophin (XmdxXWT) and display a non-dystrophic phenotype, so they are referred to as WT mice. Male offspring, described here as mdx mice, inherited only the deficient copy of dystrophin on the X chromosome (XmdxY) and display a dystrophic phenotype without Akt activation. PCR analysis was used to confirm the six possible genotypes of transgenic offspring which are categorized into the following four groups: WT STG, WT DTG, mdx STG and mdx DTG.
###end p 11
###begin p 12
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 124 146 124 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1 + MCK-rtTA</italic>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 309 330 309 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1, MCK-rtTA</italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 396 399 396 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>mdx</italic></sup>
###xml 401 403 401 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 401 403 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>WT</italic></sup>
###xml 582 585 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 598 601 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 598 601 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>mdx</italic></sup>
###xml 637 640 637 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 648 651 648 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1026 1037 1026 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 1236 1244 1236 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
###xml 1354 1357 1354 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1565 1568 1565 1568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1599 1602 1599 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
Generation of Akt-transgenic mdx mice. Breeding scheme and genotyping of offspring by PCR amplification. Double-transgenic (TRE-myrAkt1 + MCK-rtTA) male mice on a wild-type (WT) dystrophin background were crossed with mdx females. Each transgenic offspring inherited either one or both of the Akt transgenes (TRE-myrAkt1, MCK-rtTA). All female offspring, which were heterozygous for dystrophin (Xmdx XWT) and expressing non-dystrophic phenotypes, are denoted as being either wild-type single-transgenic (WT STG) or wild-type double-transgenic (WT DTG). All male offspring possessed mdx genotypes (Xmdx Y) and are denoted as being either mdx STG or mdx DTG. Transgenic offspring were genotyped through two pairs of PCR amplification reactions. In the first pair of reactions, offspring were genotyped for the two transgenes responsible for the activation of constitutively active Akt1. In the first PCR reaction, the transgene for the constitutively active form of Akt1 under the control of a tetracycline responsive promoter (TRE-myrAkt1) is amplified, yielding a 380 bp product. In the second PCR reaction, the transgene expressing a reverse tetracycline transactivator under the control of a modified muscle creatine kinase promoter (MCK-rtTA) was amplified, yielding a 567 bp product. In the second pair of reactions, offspring were genotyped for the mdx locus. The forward primers used in this pair of reactions are identical. In the first reaction of the pair, the WT allele was amplified using a WT allele-specific reverse primer. In the second reaction, the mdx allele was amplified using an mdx allele-specific reverse primer. Each reaction in this pair yielded a 275 bp product.
###end p 12
###begin title 13
###xml 64 68 <span type="species:ncbi:10090">mice</span>
DOX-induced Akt overexpression causes muscle hypertrophy in mdx mice
###end title 13
###begin p 14
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C1">1</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C6">6</xref>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C23">23</xref>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F2">2</xref>
###xml 585 588 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F2">2</xref>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 707 708 707 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 766 767 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F2">2</xref>
###xml 1025 1028 1025 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1130 1141 1130 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 1245 1256 1245 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 1260 1268 1260 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
###xml 1320 1321 1320 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F2">2</xref>
###xml 1481 1484 1481 1484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S6K</sup>
###xml 1500 1501 1500 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F2">2</xref>
###xml 1508 1511 1508 1511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S6K</sup>
###xml 1723 1725 1723 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C24">24</xref>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
Similar to DMD patients, mdx mice possess a genetic mutation in the dystrophin gene, resulting in loss of dystrophin protein and the entire DGC (1-6). The peak necrotic stage of disease occurs in mdx mice when they are between 3 and 6 weeks of age and when the frequency of degeneration/regeneration is at its greatest (23). In our model system, DOX, required for transgene activation, was administered at the prenecrotic stage of disease and mice were analyzed during peak necrosis (Fig. 2A). Increased Akt1 signaling induced obvious hind limb hypertrophy and hypervascularization in mdx mice (Fig. 2B) and increased quadriceps mass by 60% in WT (Fisher's P < 0.00001) and by 35% in mdx DTG mice (Fisher's P < 0.005) relative to their respective STG controls (Fig. 2C). Muscles from both male and female mice displayed similar levels of increased muscle mass upon transgene activation (). Immunoblotting skeletal muscle protein lysates revealed comparable expression and functionality of the Akt transgene in treated WT and mdx DTG mice. Detection of exogenous Akt was facilitated by a hemagglutinin (HA) tag engineered onto the TRE-myrAkt1 transgene. Induction of Akt transgene was restricted to DTG muscle, while STG controls with either the TRE-myrAkt1 or MCK-rtTA transgenes lacked conditional Akt activation (Fig. 2D). The level of total Akt protein overexpression in DTG muscle was increased by 2-fold relative to STG controls (). DTG muscle also exhibited activation of p70S6K and MDM2 (Fig. 2D). p70S6K is a downstream effector molecule in the mammalian target of rapamycin (mTOR) pathway which amplifies protein translation and MDM2 functions in part to enhance MyoD-controlled differentiation and transcription (24).
###end p 14
###begin p 15
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 393 394 393 394 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 421 424 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 433 436 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 617 618 617 618 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 808 809 808 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 825 828 825 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 846 847 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1017 1018 1015 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1024 1027 1022 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1033 1034 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1039 1042 1037 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1048 1049 1046 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1063 1064 1061 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1080 1081 1078 1079 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1226 1229 1224 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1239 1242 1237 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
Akt1 activation increases muscle mass in mdx mice. (A) Timeline of doxycycline (DOX) treatment of Akt STG and DTG mice. At three weeks of age, the mice were treated with DOX, inducing Akt expression in Akt DTG mice for a total of three weeks. DOX treatment period corresponds to period of maximal myofiber degeneration and regeneration in mdx mice. Tissues were analyzed at six weeks of age. (B) Representative images of mdx STG and mdx DTG mice reveal dramatic differences in muscle mass. DTG mice display increased muscle mass (asterisk) and hypervascularization (arrow) after three weeks of transgene activation. (C) Activation of Akt significantly increases muscle mass in DTG mice. Induction of transgene in DTG mice significantly increases total quadriceps weight when compared to their WT (Fisher's, *P < 0.00001) and mdx STG (Fisher's, **P < 0.005) counterparts. Quadriceps weights are represented as an average of the left and right quadriceps of each animal. Bars represent mean quadriceps weights (+/-SEM; n = 21 mdx STG, n = 4 mdx DTG. n = 18 WT STG, n = 11 WT DTG). (D) Immunoblotting for Akt pathway proteins. Akt pathway proteins were detected from total skeletal muscle lysates of six-week-old WT STG, WT DTG, mdx STG, and mdx DTG mice. Identical membranes were probed with antibodies against Akt, P-Akt, P-70S6K, P-GSK3beta, P-MDM2, and the HA-tag engineered onto the Akt1 transgene, as indicated. Coomassie blue staining of total protein is shown on the bottom panel (CB Stain) as a loading control. Activation of Akt for three weeks is sufficient for activation of P-70S6K in the Akt signaling axis. Furthermore, P-MDM2 levels increase upon Akt activation whereas P-GSK3beta levels remain constant.
###end p 15
###begin p 16
###xml 107 110 107 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F3">3</xref>
###xml 241 242 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 263 264 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F3">3</xref>
###xml 337 340 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 356 357 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 389 392 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 465 468 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 480 481 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F3">3</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
We found that Akt activation increased cross-sectional myofiber area in quadriceps muscle from both WT and mdx DTG mice (Fig. 3A and B). The distribution of fiber cross-sectional areas (CSAs) reveals increases in larger fibers (4500-7500 mum2) for DTG mice (Fig. 3B). Central nucleation, a marker for fiber regeneration, was elevated in mdx muscle (ANOVA, P < 0.005) and Akt activation in mdx mice did not significantly alter the frequency of central nucleation in mdx mice (Fig. 3C).
###end p 16
###begin p 17
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 134 137 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 462 463 461 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 633 636 632 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 652 653 651 652 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 762 765 761 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mdx</italic>
###xml 863 864 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1185 1186 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1199 1200 1198 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1213 1214 1212 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1219 1222 1218 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1228 1229 1227 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1234 1237 1233 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
Akt1 activation increases fiber hypertrophy. (A) Transverse quadriceps muscle sections from six-week-old WT STG, WT DTG, mdx STG, and mdx DTG mice were stained with hematoxylin and eosin (H&E) to visualize muscle histology. Constitutive Akt activation in mdx DTG mice did not reduce the prevalence of centrally nucleated fibers and necrosis when compared to non-phenotypic littermates. Note the muscle fiber hypertrophy in both groups of DTG mice. Bar, 50 mum. (B) Distribution of cross sectional fiber areas of quadriceps muscle. DTG mice exhibit greater populations of both smaller and hypertrophic fibers compared to their WT and mdx STG controls. (C) Central nucleation (% of total fibers) in quadriceps muscle sections was quantified in each group of mice. Mdx mice exhibit significantly higher levels of central nucleation when compared to WT mice (*ANOVA, P < 0.005). However, DTG mice do not exhibit significant differences in the amount of central nucleation when compared to their STG control littermates. Central nucleation is represented as an average of the % of central nucleation of the left and right quadriceps of each animal. Bars represent mean central nucleation. (n = 3 WT STG, n = 2 WT DTG, n = 2 mdx STG, n = 3 mdx DTG.).
###end p 17
###begin title 18
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Improved sarcolemmal integrity upon Akt1 expression in mdx DTG mice
###end title 18
###begin p 19
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F4">4</xref>
###xml 485 488 485 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F4">4</xref>
###xml 658 659 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
Loss of dystrophin and the DGC in mdx mice and in DMD patients results in contraction-induced sarcolemmal disruption and instability. Sarcolemmal integrity in mdx DTG mice was examined by the Evan's Blue Dye (EBD) tracer assay, which allows assessment of blood serum albumin infiltration into damaged muscle fibers. The quadriceps muscles of mdx STG mice displayed elevated levels of EBD infiltration compared with WT STG and DTG controls (Fig. 4A) due to the sarcolemmal fragility in mdx muscle. In contrast, Akt induction ameliorated sarcolemmal damage in mdx DTG mice to nearly WT DTG control levels (Fig. 4B; Student's t-test with Bonferroni adjustment, P < 0.03).
###end p 19
###begin p 20
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 68 69 68 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 462 465 462 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 490 491 489 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 673 674 670 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 752 753 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 777 780 770 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 786 787 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
Akt1 activation ameliorates sarcolemmal stability in mdx DTG mice. (A) Detection of blood serum protein infiltration with Evans Blue dye (EBD) tracer assay. Transverse sections of quadriceps muscle fibers with damaged sarcolemma are shown with red fluorescence. Laminin in the basement membrane is shown with green fluorescence to delineate each myofiber. EBD infiltration was absent in WT STG, detected in low levels in WT DTG and mdx DTG mice, and elevated in mdx STG mice. Bar, 50 mum. (B) Quantification of EBD-positive fibers in whole transverse quadriceps sections. Bars represent percentage of EBD infiltrated fibers in a whole quadriceps section (+/-SEM; Student's t-test with Bonferroni adjustment (alpha = 0.025), N.S. WT STG versus WT DTG, *P < 0.02, mdx DTG versus mdx STG; n = 3 mice).
###end p 20
###begin title 21
Akt activates muscle regeneration
###end title 21
###begin p 22
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C25">25</xref>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C18">18</xref>
###xml 832 833 832 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F5">5</xref>
###xml 868 872 868 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Akt1</italic>
###xml 1040 1041 1040 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F5">5</xref>
###xml 1329 1330 1329 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F5">5</xref>
###xml 1406 1407 1406 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F5">5</xref>
###xml 1702 1703 1702 1703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN358TB1">1</xref>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
The observation that central nucleation was unaffected in mdx DTG mice suggested that myofibers were undergoing regeneration despite restoration of membrane stability. Based on previous observations that Akt is involved in proliferation of satellite cells (25), we postulated that regeneration in mdx DTG muscle resulted from activation of satellite cells in Akt over-expressing muscle. In order to test this observation, we determined the myofiber CSA for WT DTG muscle after 2, 4 and 6 weeks of Akt1 transgene activation. For these studies, we chose to induce Akt activation in adult WT mice to avoid any complications of disease pathology that occur in mdx muscles (i.e. diaphragm, soleus, cardiac and EDL muscles do not express the Akt1 transgene) in this model (18). Myofiber CSA doubled after 2 weeks of Akt1 activation (Fig. 5A and B). An additional 2 weeks of Akt1 transgene activation increased the CSA by an additional 0.5-fold and no further changes in myofiber size were detected after 6 weeks of transgene overexpression (Fig. 5B). We found that the levels of central nucleation were not affected by 2 weeks of transgene activation nor were the number of nuclei per fiber changed at this time point. Interestingly, central nucleation in WT DTG muscle increased to over 20% after 4 and 6 weeks of DOX treatment (Fig. 5C), which correlated with an increase in the number of nuclei per CSA (Fig. 5D). Taken together, this data suggests that Akt1 expression in muscle activates normally quiescent satellite cells, which is further supported by the observation of elevated levels of mRNA transcripts for many satellite cell markers (myoD, pax7, PCNA, myf6 and myogenin) in WT DTG muscle (Table 1; data not shown).
###end p 22
###begin p 23
###xml 35 36 35 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 430 431 429 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 577 578 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 754 755 752 753 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1167 1168 1165 1166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1532 1533 1518 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1542 1543 1528 1529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
Akt activates muscle regeneration (A) Adult WT DTG mice were treated with DOX for two, four and six weeks. Transverse gastrocnemius muscle sections from treated WT DTG mice were stained with hematoxylin and eosin (H&E) to visualize muscle histology. Muscle sections taken from mice treated with vehicle control is shown (control). Note that muscle fiber hypertrophy is evident after two weeks of DOX administration. Bar, 50 mum. (B) Cross-sectional area (CSA) of transverse gastrocnemius WT muscle was quantified after two, four and six weeks of DOX treatment. Mean values (mum2) are provided to illustrate overall myofiber hypertrophy that is evident after two weeks of Akt1 transgene activation. Values from control, vehicle-treated muscle are shown. (C) Central nucleation (% of total fibers) in gastrocnemius muscle sections was quantified in each group of mice. Regeneration, denoted by the presence of myofibers with centrally placed nuclei, is evident in WT muscle after four weeks of Akt activation. This regeneration is occurring in the absence of muscle pathology or disease. Central nucleation is represented as an average of the % of central nucleation. (D) Quantification of the number of nuclei per myofiber is provided. No statistical (N.S.) difference in nuclei per myofiber was observed after two weeks of DOX treatment. After four and six weeks of Akt activation, the number of nuclei/myofiber increased by approximately50% relative to controls. In panels B-D, bars represent standard error of the mean (Fisher's *P < 0.05; n = 7).
###end p 23
###begin p 24
Akt1-transgene activation mediates changes in mRNA levels
###end p 24
###begin p 25
###xml 281 282 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 392 393 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Relative mRNA expression levels of utrophin, beta-DG, gamma-SG, integrin alpha7, dysferlin (dysf), MyoD as measured by qRT-PCR. mRNA levels were normalized to internal control gene 36B4 and values are represented relative to WT STG controls. Results are presented as mean +/- SEM (n = 4). Values in italics are statistically significant in comparisons for STG and DTG control sets (Fisher's, P < 0.05).
###end p 25
###begin title 26
Akt1 increases levels of several compensatory adhesion complexes
###end title 26
###begin p 27
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C1">1</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C6">6</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C16">16</xref>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F6">6</xref>
###xml 481 484 481 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F6">6</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C21">21</xref>
###xml 848 849 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F6">6</xref>
###xml 940 943 933 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 950 952 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C26">26</xref>
###xml 958 961 951 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Akt</italic>
###xml 1028 1031 1018 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 1074 1075 1064 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F6">6</xref>
###xml 1200 1201 1190 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F6">6</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
To determine the mechanism of rescue for sarcolemma fragility in DTG mdx mice, we investigated expression of several adhesion complexes that are known to rescue dystrophin deficiency and restore membrane stability (1-6,16). We found that induction of Akt signaling in mdx muscle increased protein expression of the sarcoglycan and dystroglycan subunits to WT levels (Fig. 6). Akt activation increased utrophin protein levels by a minimum of 5- and 10-fold, respectively, in WT and mdx DTG muscle, relative to their STG controls (Fig. 6). Utrophin, an autosomal homologue of dystrophin, replaces dystrophin at the post-synaptic face of the neuromuscular junction to form the UGC (21). In addition to utrophin up-regulation, dystrophin expression is up-regulated by 4-fold in WT DTG muscle thereby increasing overall levels of both DGC and UGC (Fig. 6). Similar to utrophin, integrin alpha7beta1D is up-regulated in a compensatory fashion in mdx mice (26) and Akt transgene induction increased integrin beta1D levels by 3-fold in mdx DTG muscle relative to STG controls (Fig. 6). Dysferlin, which mediates membrane repair in a calcium-dependent manner (27), was also increased in both DTG models (Fig. 6).
###end p 27
###begin p 28
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 706 709 685 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 855 858 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
Akt increases expression of compensatory proteins in mdx mice. Immunoblotting for several glycoprotein complexes (DGC, UGC, integrin) on skeletal muscle lysates from six-week-old WT STG, WT DTG, mdx STG, and mdx DTG mice. Identical membranes were probed with antibodies against dystrophin (Dys), utrophin (Utrn), alpha- and beta-dystroglycan (alpha-DG, beta-DG), alpha-, beta- and gamma-sarcoglycan (alpha-SG, beta-SG, gamma-SG), beta1D integrin and dysferlin (Dysf). GADPH immunoblotting and Coomassie blue (CB) staining of total protein are shown on the bottom panels as a loading controls. Constitutive Akt activation increased the expression of the DGC and UGC in WT mice. Utrophin levels increased in mdx mice compared to those of WT mice. Increased expression of beta1D integrin and dysferlin was observed upon Akt activation in both WT mice and in mdx mice.
###end p 28
###begin p 29
###xml 221 222 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F7">7</xref>
###xml 409 412 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 419 421 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C26">26</xref>
###xml 511 518 498 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx/utr</italic>
###xml 518 521 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 528 530 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C28">28</xref>
###xml 628 629 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDN358F7">7</xref>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
Immunohistochemical analyses revealed that the UGC and integrin beta1D, which are normally restricted to the neuromuscular junction, are broadly localized throughout the extrasynaptic sarcolemma upon Akt expression (Fig. 7). Like utrophin, the skeletal muscle-specific beta1D isoform of integrin is enriched at the neuromuscular and myotendinous junctions in WT mice, but has been found to be up-regulated in mdx mice (26). Overexpression of alpha7beta1 integrin promotes muscle hypertrophy and regeneration in mdx/utr-/- mice (28). We found integrin beta1 expression homogenously at the sarcolemma in DTG skeletal muscle (Fig. 7).
###end p 29
###begin p 30
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 623 626 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 680 683 659 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 743 746 722 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
Broad sarcolemmal distribution of compensatory proteins upon Akt activation. Immunohistochemical analyses on transverse quadriceps sections in WT STG, WT DTG, mdx STG and mdx DTG mice. Sections were stained with antibodies to dystrophin (Dys), utrophin (Utrn), beta1D integrin, alpha- and beta-dystroglycan (alpha-DG, beta-DG), alpha-, beta- and gamma-sarcoglycan (alpha-SG, beta-SG, gamma-SG) and sarcospan (SSPN), and visualized using indirect immunofluorescence. Increased expression of the DGC and UGC in WT mice was observed upon constitutive activation of Akt1. Akt activation increased expression of only the UGC in mdx mice. An increase in utrophin levels was observed in mdx mice relative to levels in WT mice. In both WT mice and in mdx mice, Akt activation increased the expression of beta1D integrin. Bar, 50 microm.
###end p 30
###begin p 31
###xml 301 302 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDN358TB1">1</xref>
###xml 403 406 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 652 654 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C29">29</xref>
###xml 810 812 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C30">30</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
To further assess the regulation of compensatory complexes, quantitative real-time PCR was performed from skeletal muscle of STG and DTG mice. mRNA levels of several genes including beta-DG, alpha7 integrin, dysferlin and MyoD were significantly elevated in DTG muscle relative to STG controls (Table 1). The observation that mRNA levels of the muscle-specific transcription factor MyoD were tripled in mdx DTG muscle supports a role for transcriptional regulation of gene expression upon Akt1 activation. Akt1 regulates skeletal muscle differentiation, at least in part, by enhancing transcriptional activity of MyoD via co-activators p300 and P/CAF (29). In turn, MyoD controls transcription of genes expressed during differentiation including alpha7 integrin, and several components of the DGC and the UGC (30).
###end p 31
###begin p 32
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C13">13</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C17">17</xref>
Here we demonstrate that myogenic expression of Akt1 in dystrophin-deficient muscle ameliorates crucial pathologies of muscular dystrophy. Our studies suggest that Akt up-regulates utrophin expression to levels that are sufficient to stabilize the sarcolemma in the absence of dystrophin and thus ameliorate muscular dystrophy. These findings provide a rationale for identification of mechanisms to increase utrophin protein stability or translation as a means to increase utrophin protein expression, in addition to current strategies to identify methods of augmenting utrophin transcription. We demonstrate for the first time that overexpression of a signaling molecule that has been suggested to control hypertrophy (13-17) can diminish the progressive muscle wasting associated with dystrophin deficiency. Akt may represent a critical 'master switch' for myofiber regeneration and modulation of these pathways may have therapeutic value for a broad-range of inherited and acquired muscle wasting disorders.
###end p 32
###begin title 33
MATERIALS AND METHODS
###end title 33
###begin title 34
Animal models
###end title 34
###begin p 35
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mdx</italic>
###xml 144 152 144 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
###xml 282 293 282 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 542 550 542 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
###xml 554 565 554 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 581 584 581 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 637 640 637 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 688 696 688 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
###xml 700 711 700 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 713 716 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 740 743 740 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 921 932 921 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 936 944 936 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 153 168 <span type="species:ncbi:10090">transgenic mice</span>
###xml 294 309 <span type="species:ncbi:10090">transgenic mice</span>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
###xml 1349 1353 <span type="species:ncbi:10090">Mice</span>
Mdx female retired breeders were purchased from Jackson Laboratories (Bar Harbor, Maine). DTG mice which were produced by crossing 1256 [3Emut] MCK-rtTA transgenic mice expressing the tetracycline transactivator controlled by a mutated skeletal muscle creatine kinase promoter with TRE-myrAkt1 transgenic mice harboring the constitutively active form of the mouse Akt1 transgene controlled by a tetracycline-responsive promoter. Male DTG mice were bred with mdx females to produce four groups of mice used for comparison: (i) Akt STG (either MCK-rtTA or TRE-myrAkt1) females on an mdx heterozygous background, (ii) Akt DTG females on an mdx heterozygous background, (iii) Akt STG (either MCK-rtTA or TRE-myrAkt1) mdx males and (iv) Akt DTG mdx males. To activate Akt transgene expression in DTG mice, three-week-old mice were treated with DOX administered in drinking water (0.5 mg/ml) for a three week period. STG mice (TRE-myrAkt1 or MCK-rtTA) treated with DOX were utilized as controls to eliminate any effect directly related to DOX treatment. After DOX treatment, quadriceps muscles and total skeletal muscles were harvested, weighed and snap-frozen in liquid nitrogen or mounted in 10.2% polyvinyl alcohol/4.3% polyethylene glycol and rapidly frozen in liquid nitrogen-cooled isopentane. All tissues were stored at -80degreesC until analyzed. Mice were housed in the Life Sciences Vivarium. All procedures were carried in accordance with guidelines set by the UCLA Institutional Animal Care and Use Committee.
###end p 35
###begin title 36
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Genotyping of Akt-transgenic mdx mice
###end title 36
###begin title 37
Akt genotyping
###end title 37
###begin p 38
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C18">18</xref>
###xml 94 105 94 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRE-myrAkt1</italic>
###xml 454 462 430 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-rtTA</italic>
PCR amplifications for transgenes were carried out as previously described (18). Briefly, the TRE-myrAkt1 transgene was amplified using the following primers: Tet-Akt #1 (5'-CTGGACTACTTGCACTCCGAGAAG-3') and Tet-Akt #2 (5'-CTGTGTAGGGTCCTTCTTGAGCAG-3'). The cycling conditions were 95degreesC, 5 min; then 95degreesC, 30 s and 68degreesC, 30 s for 30 cycles, followed by 72degreesC, 10 min. The reaction yielded a 380 bp product. PCR amplifications of the MCK-rtTA transgene was amplified using the following primers: MCK-rtTA #1 (5'-CATCTGCGGACTGGAAAAACAAC-3') and MCK-rtTA #2 (5'-GCATCGGTAAACATCTGCTCAAAC-3'). The cycling conditions were 95degreesC, 5 min; then 94degreesC, 30 s; 62degreesC, 30 s and 72degreesC, 1 min. for 30 cycles, followed by 72degreesC, 10 min. The reaction yielded a 567 bp product.
###end p 38
###begin title 39
Mdx genotyping
###end title 39
###begin p 40
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C31">31</xref>
###xml 353 356 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 375 378 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
The mdx point mutation was screened using a modified version of an amplification-resistant mutation system (ARMS) assay (31). Two separate PCR reactions were performed. The WT PCR amplifies the WT dystrophin allele using the following oligonucleotide primers: p260E (5'-GTCACTCAGATAGTTGAAGCCATTTAG-3') and p306F (5'-CATAGTTATTAATGCATAGATATTCAG-3'). The mdx PCR amplifies the mdx allele using the following oligonucleotide primers: p259E (5'-GTCACTCAGATAGTTGAAGCCATTTAA-3') and p306F (5'-CATAGTTATTAATGCATAGATATTCAG-3'). PCR cycling conditions for both reactions were 95degreesC, 4 min; then 95degreesC, 1 min; 55degreesC, 1 min and 72degreesC, 1 min for 34 cycles, followed by 72degreesC, 10 min. Each reaction yielded a 275 bp product. All PCR reactions utilized the GoTaq DNA Polymerase kit (Promega, Madison, WI, USA).
###end p 40
###begin title 41
Protein preparation
###end title 41
###begin p 42
###xml 197 198 197 198 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 235 236 235 236 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 258 259 258 259 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 280 281 280 281 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 308 309 305 306 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 337 338 334 335 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 356 357 353 354 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 381 382 378 379 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 576 577 570 571 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 599 600 593 594 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 776 777 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Snap-frozen skeletal muscles were crushed with liquid nitrogen and a mortar and pestle. Ice-cold RIPA lysis buffer [1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 1 mm ethylenediaminetetraacetic acid, 5 mmN-ethylmaleimide, 50 mm sodium fluoride, 2 mm beta-glycerophosphate, 1 mm sodium orthovanadate, 100 nm okadaic acid, 5 nm microcystin LR and 20 mm Tris-HCl, pH 7.6) was utilized for homogenization. Immediately before addition of crushed tissue, protease inhibitors (0.6 mug/ml pepstatin A, 0.5 mug/ml aprotinin, 0.5 mug/ml leupeptin, 0.75 mm benzamidine and 0.1 mm phenylmethylsulfonyl fluoride) were added to the lysis buffer. Homogenates were rocked at 4degreesC for 1 h. Clarified lysates were obtained following centrifugation at 15 000g for 15 min. Clarified tissue lysates were stored at -80degreesC until analyzed by immunoblot analysis.
###end p 42
###begin title 43
Immunoblot analysis
###end title 43
###begin p 44
###xml 1272 1274 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C32">32</xref>
###xml 1238 1244 <span type="species:ncbi:9986">Rabbit</span>
###xml 1512 1516 <span type="species:ncbi:9925">Goat</span>
###xml 1559 1570 <span type="species:ncbi:3704">horseradish</span>
###xml 1598 1602 <span type="species:ncbi:9925">goat</span>
###xml 1650 1656 <span type="species:ncbi:9986">Rabbit</span>
###xml 1699 1710 <span type="species:ncbi:3704">horseradish</span>
###xml 1738 1744 <span type="species:ncbi:9986">rabbit</span>
###xml 1808 1813 <span type="species:ncbi:10090">Mouse</span>
###xml 1877 1888 <span type="species:ncbi:3704">horseradish</span>
###xml 1916 1921 <span type="species:ncbi:10090">mouse</span>
Protein concentrations of clarified tissue lysates were determined using the DC Protein Assay (Bio-Rad). Equal concentrations of protein samples (60 microg) were resolved by 4-20% gradient SDS-PAGE (Pierce, Rockford, IL, USA) and transferred to nitrocellulose membranes (Millipore Corp., Billerica, MA, USA) for subsequent immunoblot experiments. Primary antibodies against Akt, phosphorylated Akt (Ser 473) and phosphorylated GSK3beta (Cell Signaling Technologies, Beverly, MA, #9272, #9271 and #9336, respectively) were diluted 1:750. Phosphorylated p70S6K (Cell Signaling Technologies, #9205) was used at a 1:250 dilution. beta1D Integrin (Temecula California; International, MAB1900) was diluted 1:100. Primary antibodies against proteins in the DGC and UGC and their respective concentrations include dystrophin (Vector Laboratories, Burlingame, CA, USA; VP-D507, 1:2), utrophin (University of Iowa, Hybridoma Facility; MANCHO3, 1:200), alpha-DG (Upstate Cell Signaling Solutions, Lake Placid, NY, USA; IIH6, 1:700), beta-DG (University of Iowa, Hybridoma Facility; MANDAG2, 1:10), alpha-SG (Vector Laboratories; VP-A105, 1:20), beta-SG (Vector Laboratories; VP-B206, 1:100), gamma-SG (Vector Laboratories; VP-G803, 1:200) and SSPN [Rabbit 3 (described previously in 32), 1:50]. alpha7 Integrin antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA; L-17) was diluted 1:100 and alpha5 integrin (Abcam, Cambridge, UK; ab55988) was diluted 1:50. Anti-dysferlin antibody (Abcam; ab15108) was diluted 1:600. Goat polyclonal antibodies were detected using horseradish peroxidase-conjugated anti-goat IgG (Santa Cruz Biotechnology, Inc.; SC-2033). Rabbit polyclonal antibodies were detected using horseradish peroxidase-conjugated anti-rabbit IgG (Amersham Pharmacia Biotech, Piscataway, NJ, USA, #NA934). Mouse monoclonal primary antibodies were detected by incubating with horseradish peroxidase-conjugated anti-mouse IgG or IgM (Amersham Pharmacia Biotech, 1:3000; Roche Applied Science, Indianapolis, IN, USA; 1:1000, respectively) for 1 h. Immunoblots were developed using enhanced chemiluminescence with SuperSignal West Pico Chemiluminescent Substrate (Pierce, # 34080).
###end p 44
###begin title 45
Histology
###end title 45
###begin p 46
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C11">11</xref>
Hematoxylin and eosin (H&E) staining was used for visualization of fibrosis, central nucleation and cross-sectional fiber area as previously described (11). Transverse quadriceps sections were left at RT for 15 min prior to staining. Briefly, muscle sections were incubated with hematoxylin for 3 min, washed with water for 1 min, incubated with eosin for 3 min, dehydrated in solutions of 70, 80, 90 and 100% ethanol and then incubated in xylene for a total of 10 min. Stained sections were mounted with permount. All supplies for the H&E staining were purchased from Fisher Scientific (Fairlawn, NJ, USA). Centrally nucleated fibers and cross-sectional fiber area were measured from digitized images captured under identical conditions with an Axioplan 2 fluorescent microscope (Carl Zeiss Inc., Thornwood, NY, USA) and Axiovision 4.5 software (Carl Zeiss Inc.). Central nucleation was quantified as a percentage of centrally nucleated fibers over the total number of fibers in an entire transverse quadriceps section. CSA of fiber diameters was calculated using the outline spline function on the Axiovision 4.5 software. For adult studies, DOX treatment was started at the age of 10 weeks.
###end p 46
###begin title 47
Evan's blue tracer assay
###end title 47
###begin p 48
###xml 162 163 161 162 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 187 188 186 187 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1207 1232 1199 1224 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://rsbweb.nih.gov/ij/">http://rsbweb.nih.gov/ij/</uri>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 813 819 <span type="species:ncbi:9986">rabbit</span>
To assess sarcolemmal permeability, 6-week-old mice were intraperitoneally injected (50 mul per 10 g of body weight) with sterilized EBD (10 mg/ml in sterile 10 mm phosphate buffer, 150 mm NaCl, pH 7.4). Twenty-four hours post-injection, muscles were excised and frozen in liquid nitrogen-cooled isopentane. Transverse quadriceps cryosections (8 mum) were prepared using a CM 3050S cryostat (Leica Microsystems, Bannockburn, IL, USA). Sections were incubated with ice-cold acetone, washed with PBS and blocked for 1 h at RT with 3% BSA diluted in PBS. For sarcolemmal visualization of EBD infiltrated fibers, sections were incubated at 4degreesC for 18 h with an antibody to laminin (Sigma, St Louis, MO, USA; L 9393) diluted at 1:25 in 1% BSA in PBS. Sections were incubated at RT for 1 h with biotinylated anti-rabbit antibody (Vector Laboratories; BA-1000, 1:250) and then with fluorescein avidin D (Vector Laboratories; A-2001, 1:250). Sections were mounted in VectaShield (Vector Laboratories; H-1000) and imaged using the Axioplan 2 fluorescent microscope with green and blue excitation filters and the Axiovision 4.5 software (Carl Zeiss Inc.). Images were merged using ImageJ software (available on http://rsbweb.nih.gov/ij/). Quantification of sarcolemmal integrity was quantified as a percentage of EBD-positive fibers over the total number of fibers counted in an entire transverse quadriceps section. Data represented is the average percentage of EBD-positive fibers in both quadriceps of each animal.
###end p 48
###begin title 49
Immunofluorescence
###end title 49
###begin p 50
###xml 916 921 <span type="species:ncbi:10090">mouse</span>
###xml 1266 1272 <span type="species:ncbi:9986">Rabbit</span>
###xml 1369 1374 <span type="species:ncbi:10090">mouse</span>
###xml 1423 1429 <span type="species:ncbi:9986">rabbit</span>
Transverse sections were prepared from quadriceps muscles as described earlier. All sections, except for those used for detecting alpha-DG and SSPN, were acclimated to RT for 15 min and then blocked with 3% BSA diluted in PBS for 30 min. The Vector(R) M.O.M.trade mark Immunodetection Kit (Vector Laboratories) was then used on these sections following manufacturer's instructions. Primary antibodies diluted in M.O.M. diluent were incubated at 4degreesC for 18 h against their respective proteins as follows: dystrophin (University of Iowa, Hybridoma Facility; MANDYS1, 1:30), utrophin (Vector Laboratories; VP-U579, 1:5), beta1D integrin (Chemicon International; MAB1900, 1:25), beta-DG (Vector; VP-B205 1:15), alpha-SG (Vector Laboratories; VP-A105, 1:30), beta-SG (Vector Laboratories; VP-B206, 1:30), gamma-SG (Vector Laboratories; VP-G803, 1:15). Afterwards, the sections were incubated with biotinylated anti-mouse antibody (1:250) provided in the M.O.M. kit and then with fluorescein avidin D (Vector Laboratories; A-2001, 1:250). Sections used for detecting alpha-DG and SSPN were blocked in 3% BSA diluted in PBS followed by primary antibody incubations at 4degreesC for 18 h as follows: alpha-DG (Upstate Cell Signaling Solutions; VIA4-1, 1:20) and SSPN (Rabbit 3, 1:5). These primary antibodies were detected by incubating for 1 h with FITC-conjugated anti-mouse secondary antibody or with FITC-conjugated anti-rabbit secondary antibody (Jackson ImmunoResearch, West Grove, PA; each, 1:500) for alpha-DG and SSPN, respectively. Sections were mounted in VectaShield (Vector Laboratories). Images were obtained using the Axioplan 2 fluorescent microscope and Axiovision 4.5 software (Carl Zeiss Inc.).
###end p 50
###begin title 51
Statistical analyses
###end title 51
###begin p 52
###xml 497 498 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 539 540 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 592 593 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 869 872 867 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
Central nucleation, EBD and quadriceps mass data were represented as means +/- SEM. The mean for each variable is calculated as means of the average between the values from the left and right quadriceps of each animal. A two-way ANOVA followed by Fisher's protected least significant difference (Fisher's PLSD) method and the Kruskal-Wallis nonparametric test was used for statistical analysis (Origin 7.0 Software; OriginLab Corporation; Northampton, MA). Values were considered significant when P < 0.05. For EBD analysis, the Student's t-test with Bonferroni adjustment to significance at P < 0.025 was used. Decreases in EBD fibers in WT DTG relative to WT STG mice could not be observed because levels of EBD-positive fibers were already near zero. Because of this, the two-way ANOVA was not sufficient in assessing the decrease in EBD-positive fibers seen in the mdx mice.
###end p 52
###begin title 53
Quantitative real-time PCR
###end title 53
###begin p 54
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDN358C18">18</xref>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
Total RNA from whole skeletal muscle was prepared by QIAGEN RNeasy kit using manufacturer protocols. cDNA was produced using the ThermoScript RT-PCR System (Invitrogen). Real-time PCR was performed as described previously (18). Transcript levels were determined relative to the signal from 36B4 and normalized to the mean value of samples from WT STG control mice. Primer sequences for each gene are as follows: utrophin (forward, 5'-GTTTGAGGTGCTTCCTCAGC-3'; reverse, 5'-GCGCTATCTGGTAGCTGTCC-3'); gene 36B4 (forward, 5'-GCTCCAAGCAGATGCAGCA-3'; reverse, 5'-CCGGATGTGAGGCAGCAG-3'); beta-DG (forward, 5'-CTGGAAGAACCAGCTTGAGG-3'; reverse, 5'-AAATCCGTTGGAATGCTCAC-3'); gamma-SG (forward, 5'-TGAAACTGTGGGTTTGACCA-3'; reverse, 5'-GGTACAGCTTCCCATCAGGA-3'); dysferlin (forward, 5'-AACACTGGGTCCCTGTTGAG-3'; reverse, 5'-GCCTCTTCAGTGCTTCCATC-3'); MyoD (forward, 5'-AGCACGCACACTTCCCTACT-3'; reverse, 5'-TCTCGAAGGCCTCATTCACT-3'); integrin alpha7 (forward, 5'-CTCTGCGTTCCTCAACATCA-3'; reverse, 5'-TGTGCTAGGCTCCACCTTCT-3').
###end p 54
###begin title 55
SUPPLEMENTARY MATERIAL
###end title 55
###begin p 56
.
###end p 56
###begin title 57
FUNDING
###end title 57
###begin p 58
###xml 38 84 38 84 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Molecular, Cellular and Integrative Physiology</grant-sponsor>
###xml 119 135 119 135 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH: T32 GM65823</grant-num>
###xml 171 295 171 295 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Edith Hyde Fellowship, the Ursula Mandel Fellowship, and the Harold and Lillian Kraus American Heart Pre-doctoral Fellowship</grant-sponsor>
###xml 414 446 414 446 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">American Heart Association grant</grant-sponsor>
###xml 470 499 470 499 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</grant-sponsor>
###xml 499 546 499 546 <!-- oupReleaseDelayRemoved from OA Article (12|0) -->
###xml 548 561 548 561 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grant HL81587</grant-num>
###xml 592 595 592 595 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH</grant-sponsor>
###xml 595 642 595 642 <!-- oupReleaseDelayRemoved from OA Article (12|0) -->
###xml 644 654 644 654 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AR48179-01</grant-num>
###xml 660 694 660 694 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">the Muscular Dystrophy Association</grant-sponsor>
###xml 696 703 696 703 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDA3704</grant-num>
A.K.P. and C.K. were supported by the Molecular, Cellular and Integrative Physiology pre-doctoral training fellowship (NIH: T32 GM65823). A.K.P. was also supported by the Edith Hyde Fellowship, the Ursula Mandel Fellowship, and the Harold and Lillian Kraus American Heart Pre-doctoral Fellowship and Training in Cardiovascular Physiology and Pharmacology Training Grant (5T32HL007444-27). N.O. was supported by an American Heart Association grant. K.W. was supported by National Institutes of Health oupReleaseDelayRemoved from OA Article (12|0)  (grant HL81587). R.H.C. was supported by the NIH oupReleaseDelayRemoved from OA Article (12|0)  (AR48179-01) and the Muscular Dystrophy Association (MDA3704).
###end p 58
###begin title 59
Supplementary Material
###end title 59
###begin title 60
[Supplementary Data]
###end title 60
###begin title 61
ACKNOWLEDGEMENTS
###end title 61
###begin p 62
We thank Dr M. Song and J.L. Marshall (UCLA) for technical assistance.
###end p 62
###begin p 63
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 63
###begin title 64
REFERENCES
###end title 64
###begin article-title 65
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
###end article-title 65
###begin article-title 66
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
###end article-title 66
###begin article-title 67
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
###end article-title 67
###begin article-title 68
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models
###end article-title 68
###begin article-title 69
Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy
###end article-title 69
###begin article-title 70
Association of dystrophin and an integral membrane glycoprotein
###end article-title 70
###begin article-title 71
Membrane organization of the dystrophin-glycoprotein complex
###end article-title 71
###begin article-title 72
Purification of dystrophin from skeletal muscle
###end article-title 72
###begin article-title 73
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
###end article-title 73
###begin article-title 74
Glycoprotein complex anchoring dystrophin to sarcolemma
###end article-title 74
###begin article-title 75
Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway
###end article-title 75
###begin article-title 76
Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch
###end article-title 76
###begin article-title 77
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
###end article-title 77
###begin article-title 78
Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth
###end article-title 78
###begin article-title 79
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
###end article-title 79
###begin article-title 80
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
###end article-title 80
###begin article-title 81
A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification
###end article-title 81
###begin article-title 82
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice
###end article-title 82
###begin article-title 83
Intracellular signaling during skeletal muscle atrophy
###end article-title 83
###begin article-title 84
The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system
###end article-title 84
###begin article-title 85
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Expression of full-length utrophin prevents muscular dystrophy in mdx mice
###end article-title 85
###begin article-title 86
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mdx</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
###end article-title 86
###begin article-title 87
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse
###end article-title 87
###begin article-title 88
MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206
###end article-title 88
###begin article-title 89
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis
###end article-title 89
###begin article-title 90
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 60 66 <span type="species:ncbi:10090">murine</span>
Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies
###end article-title 90
###begin article-title 91
Defective membrane repair in dysferlin-deficient muscular dystrophy
###end article-title 91
###begin article-title 92
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice
###end article-title 92
###begin article-title 93
Selective control of skeletal muscle differentiation by Akt1
###end article-title 93
###begin article-title 94
The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription
###end article-title 94
###begin article-title 95
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin
###end article-title 95
###begin article-title 96
Over-expression of Microspan, a novel component of the sarcoplasmic reticulum, causes severe muscle pathology with triad abnormalities
###end article-title 96

